Global Molecular Diagnosis and Therapy Market Growth (Status and Outlook) 2025-2031

September 2025 | 117 pages | ID: G66737B3E705EN
LP Information

Abstracts

According to this study, the global Molecular Diagnosis and Therapy market size will reach US$ million by 2031.

Molecular Diagnosis & Therapy provides researchers and healthcare professionals with insights into the latest molecular diagnostic and therapeutic techniques and their use in precision medicine.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Molecular Diagnosis and Therapy Industry Forecast” looks at past sales and reviews total world Molecular Diagnosis and Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Molecular Diagnosis and Therapy sales for 2025 through 2031. With Molecular Diagnosis and Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Diagnosis and Therapy industry.

This Insight Report provides a comprehensive analysis of the global Molecular Diagnosis and Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Molecular Diagnosis and Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular Diagnosis and Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Diagnosis and Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Diagnosis and Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Diagnosis and Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:

• PCR
• DNA Sequencing
• NGS

Segmentation by Application:

• Diagnostic Laboratories
• Research & Academic Laboratories

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Abbott Laboratories
• Agilent Technologies
• Becton, Dickinson and Company
• Biom?rieux Sa
• Danaher Corporation
• Diasorin
• Grifols
• Hologic
• Illumina
• Qiagen
• Roche Diagnostics
• Siemens AG
• Thermo Fisher Scientific

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Molecular Diagnosis and Therapy Market Size (2020-2031)
  2.1.2 Molecular Diagnosis and Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Molecular Diagnosis and Therapy by Country/Region (2020, 2024 & 2031)
2.2 Molecular Diagnosis and Therapy Segment by Type
  2.2.1 PCR
  2.2.2 DNA Sequencing
  2.2.3 NGS
2.3 Molecular Diagnosis and Therapy Market Size by Type
  2.3.1 Molecular Diagnosis and Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Molecular Diagnosis and Therapy Market Size Market Share by Type (2020-2025)
2.4 Molecular Diagnosis and Therapy Segment by Application
  2.4.1 Diagnostic Laboratories
  2.4.2 Research & Academic Laboratories
2.5 Molecular Diagnosis and Therapy Market Size by Application
  2.5.1 Molecular Diagnosis and Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Molecular Diagnosis and Therapy Market Size Market Share by Application (2020-2025)

3 MOLECULAR DIAGNOSIS AND THERAPY MARKET SIZE BY PLAYER

3.1 Molecular Diagnosis and Therapy Market Size Market Share by Player
  3.1.1 Global Molecular Diagnosis and Therapy Revenue by Player (2020-2025)
  3.1.2 Global Molecular Diagnosis and Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Molecular Diagnosis and Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MOLECULAR DIAGNOSIS AND THERAPY BY REGION

4.1 Molecular Diagnosis and Therapy Market Size by Region (2020-2025)
4.2 Global Molecular Diagnosis and Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Molecular Diagnosis and Therapy Market Size Growth (2020-2025)
4.4 APAC Molecular Diagnosis and Therapy Market Size Growth (2020-2025)
4.5 Europe Molecular Diagnosis and Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Molecular Diagnosis and Therapy Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Molecular Diagnosis and Therapy Market Size by Country (2020-2025)
5.2 Americas Molecular Diagnosis and Therapy Market Size by Type (2020-2025)
5.3 Americas Molecular Diagnosis and Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Molecular Diagnosis and Therapy Market Size by Region (2020-2025)
6.2 APAC Molecular Diagnosis and Therapy Market Size by Type (2020-2025)
6.3 APAC Molecular Diagnosis and Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Molecular Diagnosis and Therapy Market Size by Country (2020-2025)
7.2 Europe Molecular Diagnosis and Therapy Market Size by Type (2020-2025)
7.3 Europe Molecular Diagnosis and Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Molecular Diagnosis and Therapy by Region (2020-2025)
8.2 Middle East & Africa Molecular Diagnosis and Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Molecular Diagnosis and Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL MOLECULAR DIAGNOSIS AND THERAPY MARKET FORECAST

10.1 Global Molecular Diagnosis and Therapy Forecast by Region (2026-2031)
  10.1.1 Global Molecular Diagnosis and Therapy Forecast by Region (2026-2031)
  10.1.2 Americas Molecular Diagnosis and Therapy Forecast
  10.1.3 APAC Molecular Diagnosis and Therapy Forecast
  10.1.4 Europe Molecular Diagnosis and Therapy Forecast
  10.1.5 Middle East & Africa Molecular Diagnosis and Therapy Forecast
10.2 Americas Molecular Diagnosis and Therapy Forecast by Country (2026-2031)
  10.2.1 United States Market Molecular Diagnosis and Therapy Forecast
  10.2.2 Canada Market Molecular Diagnosis and Therapy Forecast
  10.2.3 Mexico Market Molecular Diagnosis and Therapy Forecast
  10.2.4 Brazil Market Molecular Diagnosis and Therapy Forecast
10.3 APAC Molecular Diagnosis and Therapy Forecast by Region (2026-2031)
  10.3.1 China Molecular Diagnosis and Therapy Market Forecast
  10.3.2 Japan Market Molecular Diagnosis and Therapy Forecast
  10.3.3 Korea Market Molecular Diagnosis and Therapy Forecast
  10.3.4 Southeast Asia Market Molecular Diagnosis and Therapy Forecast
  10.3.5 India Market Molecular Diagnosis and Therapy Forecast
  10.3.6 Australia Market Molecular Diagnosis and Therapy Forecast
10.4 Europe Molecular Diagnosis and Therapy Forecast by Country (2026-2031)
  10.4.1 Germany Market Molecular Diagnosis and Therapy Forecast
  10.4.2 France Market Molecular Diagnosis and Therapy Forecast
  10.4.3 UK Market Molecular Diagnosis and Therapy Forecast
  10.4.4 Italy Market Molecular Diagnosis and Therapy Forecast
  10.4.5 Russia Market Molecular Diagnosis and Therapy Forecast
10.5 Middle East & Africa Molecular Diagnosis and Therapy Forecast by Region (2026-2031)
  10.5.1 Egypt Market Molecular Diagnosis and Therapy Forecast
  10.5.2 South Africa Market Molecular Diagnosis and Therapy Forecast
  10.5.3 Israel Market Molecular Diagnosis and Therapy Forecast
  10.5.4 Turkey Market Molecular Diagnosis and Therapy Forecast
10.6 Global Molecular Diagnosis and Therapy Forecast by Type (2026-2031)
10.7 Global Molecular Diagnosis and Therapy Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Molecular Diagnosis and Therapy Forecast

11 KEY PLAYERS ANALYSIS

11.1 Abbott Laboratories
  11.1.1 Abbott Laboratories Company Information
  11.1.2 Abbott Laboratories Molecular Diagnosis and Therapy Product Offered
  11.1.3 Abbott Laboratories Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Abbott Laboratories Main Business Overview
  11.1.5 Abbott Laboratories Latest Developments
11.2 Agilent Technologies
  11.2.1 Agilent Technologies Company Information
  11.2.2 Agilent Technologies Molecular Diagnosis and Therapy Product Offered
  11.2.3 Agilent Technologies Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Agilent Technologies Main Business Overview
  11.2.5 Agilent Technologies Latest Developments
11.3 Becton, Dickinson and Company
  11.3.1 Becton, Dickinson and Company Company Information
  11.3.2 Becton, Dickinson and Company Molecular Diagnosis and Therapy Product Offered
  11.3.3 Becton, Dickinson and Company Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Becton, Dickinson and Company Main Business Overview
  11.3.5 Becton, Dickinson and Company Latest Developments
11.4 Biom?rieux Sa
  11.4.1 Biom?rieux Sa Company Information
  11.4.2 Biom?rieux Sa Molecular Diagnosis and Therapy Product Offered
  11.4.3 Biom?rieux Sa Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Biom?rieux Sa Main Business Overview
  11.4.5 Biom?rieux Sa Latest Developments
11.5 Danaher Corporation
  11.5.1 Danaher Corporation Company Information
  11.5.2 Danaher Corporation Molecular Diagnosis and Therapy Product Offered
  11.5.3 Danaher Corporation Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Danaher Corporation Main Business Overview
  11.5.5 Danaher Corporation Latest Developments
11.6 Diasorin
  11.6.1 Diasorin Company Information
  11.6.2 Diasorin Molecular Diagnosis and Therapy Product Offered
  11.6.3 Diasorin Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Diasorin Main Business Overview
  11.6.5 Diasorin Latest Developments
11.7 Grifols
  11.7.1 Grifols Company Information
  11.7.2 Grifols Molecular Diagnosis and Therapy Product Offered
  11.7.3 Grifols Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Grifols Main Business Overview
  11.7.5 Grifols Latest Developments
11.8 Hologic
  11.8.1 Hologic Company Information
  11.8.2 Hologic Molecular Diagnosis and Therapy Product Offered
  11.8.3 Hologic Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Hologic Main Business Overview
  11.8.5 Hologic Latest Developments
11.9 Illumina
  11.9.1 Illumina Company Information
  11.9.2 Illumina Molecular Diagnosis and Therapy Product Offered
  11.9.3 Illumina Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Illumina Main Business Overview
  11.9.5 Illumina Latest Developments
11.10 Qiagen
  11.10.1 Qiagen Company Information
  11.10.2 Qiagen Molecular Diagnosis and Therapy Product Offered
  11.10.3 Qiagen Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Qiagen Main Business Overview
  11.10.5 Qiagen Latest Developments
11.11 Roche Diagnostics
  11.11.1 Roche Diagnostics Company Information
  11.11.2 Roche Diagnostics Molecular Diagnosis and Therapy Product Offered
  11.11.3 Roche Diagnostics Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Roche Diagnostics Main Business Overview
  11.11.5 Roche Diagnostics Latest Developments
11.12 Siemens AG
  11.12.1 Siemens AG Company Information
  11.12.2 Siemens AG Molecular Diagnosis and Therapy Product Offered
  11.12.3 Siemens AG Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Siemens AG Main Business Overview
  11.12.5 Siemens AG Latest Developments
11.13 Thermo Fisher Scientific
  11.13.1 Thermo Fisher Scientific Company Information
  11.13.2 Thermo Fisher Scientific Molecular Diagnosis and Therapy Product Offered
  11.13.3 Thermo Fisher Scientific Molecular Diagnosis and Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Thermo Fisher Scientific Main Business Overview
  11.13.5 Thermo Fisher Scientific Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Molecular Diagnosis and Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Molecular Diagnosis and Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of PCR
Table 4. Major Players of DNA Sequencing
Table 5. Major Players of NGS
Table 6. Molecular Diagnosis and Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Molecular Diagnosis and Therapy Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Molecular Diagnosis and Therapy Market Size Market Share by Type (2020-2025)
Table 9. Molecular Diagnosis and Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Molecular Diagnosis and Therapy Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Molecular Diagnosis and Therapy Market Size Market Share by Application (2020-2025)
Table 12. Global Molecular Diagnosis and Therapy Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Molecular Diagnosis and Therapy Revenue Market Share by Player (2020-2025)
Table 14. Molecular Diagnosis and Therapy Key Players Head office and Products Offered
Table 15. Molecular Diagnosis and Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Molecular Diagnosis and Therapy Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Molecular Diagnosis and Therapy Market Size Market Share by Region (2020-2025)
Table 20. Global Molecular Diagnosis and Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Molecular Diagnosis and Therapy Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Molecular Diagnosis and Therapy Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Molecular Diagnosis and Therapy Market Size Market Share by Country (2020-2025)
Table 24. Americas Molecular Diagnosis and Therapy Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Molecular Diagnosis and Therapy Market Size Market Share by Type (2020-2025)
Table 26. Americas Molecular Diagnosis and Therapy Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Molecular Diagnosis and Therapy Market Size Market Share by Application (2020-2025)
Table 28. APAC Molecular Diagnosis and Therapy Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Molecular Diagnosis and Therapy Market Size Market Share by Region (2020-2025)
Table 30. APAC Molecular Diagnosis and Therapy Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Molecular Diagnosis and Therapy Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Molecular Diagnosis and Therapy Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Molecular Diagnosis and Therapy Market Size Market Share by Country (2020-2025)
Table 34. Europe Molecular Diagnosis and Therapy Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Molecular Diagnosis and Therapy Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Molecular Diagnosis and Therapy Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Molecular Diagnosis and Therapy Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Molecular Diagnosis and Therapy Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Molecular Diagnosis and Therapy
Table 40. Key Market Challenges & Risks of Molecular Diagnosis and Therapy
Table 41. Key Industry Trends of Molecular Diagnosis and Therapy
Table 42. Global Molecular Diagnosis and Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Molecular Diagnosis and Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Molecular Diagnosis and Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Molecular Diagnosis and Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Abbott Laboratories Details, Company Type, Molecular Diagnosis and Therapy Area Served and Its Competitors
Table 47. Abbott Laboratories Molecular Diagnosis and Therapy Product Offered
Table 48. Abbott Laboratories Molecular Diagnosis and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Abbott Laboratories Main Business
Table 50. Abbott Laboratories Latest Developments
Table 51. Agilent Technologies Details, Company Type, Molecular Diagnosis and Therapy Area Served and Its Competitors
Table 52. Agilent Technologies Molecular Diagnosis and Therapy Product Offered
Table 53. Agilent Technologies Molecular Diagnosis and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Agilent Technologies Main Business
Table 55. Agilent Technologies Latest Developments
Table 56. Becton, Dickinson and Company Details, Company Type, Molecular Diagnosis and Therapy Area Served and Its Competitors
Table 57. Becton, Dickinson and Company Molecular Diagnosis and Therapy Product Offered
Table 58. Becton, Dickinson and Company Molecular Diagnosis and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Becton, Dickinson and Company Main Business
Table 60. Becton, Dickinson and Company Latest Developments
Table 61. Biom?rieux Sa Details, Company Type, Molecular Diagnosis and Therapy Area Served and Its Competitors
Table 62. Biom?rieux Sa Molecular Diagnosis and Therapy Product Offered
Table 63. Biom?rieux Sa Molecular Diagnosis and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Biom?rieux Sa Main Business
Table 65. Biom?rieux Sa Latest Developments
Table 66. Danaher Corporation Details, Company Type, Molecular Diagnosis and Therapy Area Served and Its Competitors
Table 67. Danaher Corporation Molecular Diagnosis and Therapy Product Offered
Table 68. Danaher Corporation Molecular Diagnosis and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Danaher Corporation Main Business
Table 70. Danaher Corporation Latest Developments
Table 71. Diasorin Details, Company Type, Molecular Diagnosis and Therapy Area Served and Its Competitors
Table 72. Diasorin Molecular Diagnosis and Therapy Product Offered
Table 73. Diasorin Molecular Diagnosis and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Diasorin Main Business
Table 75. Diasorin Latest Developments
Table 76. Grifols Details, Company Type, Molecular Diagnosis and Therapy Area Served and Its Competitors
Table 77. Grifols Molecular Diagnosis and Therapy Product Offered
Table 78. Grifols Molecular Diagnosis and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Grifols Main Business
Table 80. Grifols Latest Developments
Table 81. Hologic Details, Company Type, Molecular Diagnosis and Therapy Area Served and Its Competitors
Table 82. Hologic Molecular Diagnosis and Therapy Product Offered
Table 83. Hologic Molecular Diagnosis and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Hologic Main Business
Table 85. Hologic Latest Developments
Table 86. Illumina Details, Company Type, Molecular Diagnosis and Therapy Area Served and Its Competitors
Table 87. Illumina Molecular Diagnosis and Therapy Product Offered
Table 88. Illumina Molecular Diagnosis and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Illumina Main Business
Table 90. Illumina Latest Developments
Table 91. Qiagen Details, Company Type, Molecular Diagnosis and Therapy Area Served and Its Competitors
Table 92. Qiagen Molecular Diagnosis and Therapy Product Offered
Table 93. Qiagen Molecular Diagnosis and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Qiagen Main Business
Table 95. Qiagen Latest Developments
Table 96. Roche Diagnostics Details, Company Type, Molecular Diagnosis and Therapy Area Served and Its Competitors
Table 97. Roche Diagnostics Molecular Diagnosis and Therapy Product Offered
Table 98. Roche Diagnostics Molecular Diagnosis and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Roche Diagnostics Main Business
Table 100. Roche Diagnostics Latest Developments
Table 101. Siemens AG Details, Company Type, Molecular Diagnosis and Therapy Area Served and Its Competitors
Table 102. Siemens AG Molecular Diagnosis and Therapy Product Offered
Table 103. Siemens AG Molecular Diagnosis and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Siemens AG Main Business
Table 105. Siemens AG Latest Developments
Table 106. Thermo Fisher Scientific Details, Company Type, Molecular Diagnosis and Therapy Area Served and Its Competitors
Table 107. Thermo Fisher Scientific Molecular Diagnosis and Therapy Product Offered
Table 108. Thermo Fisher Scientific Molecular Diagnosis and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Thermo Fisher Scientific Main Business
Table 110. Thermo Fisher Scientific Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Molecular Diagnosis and Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Molecular Diagnosis and Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Molecular Diagnosis and Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Molecular Diagnosis and Therapy Sales Market Share by Country/Region (2024)
Figure 8. Molecular Diagnosis and Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Molecular Diagnosis and Therapy Market Size Market Share by Type in 2024
Figure 10. Molecular Diagnosis and Therapy in Diagnostic Laboratories
Figure 11. Global Molecular Diagnosis and Therapy Market: Diagnostic Laboratories (2020-2025) & ($ millions)
Figure 12. Molecular Diagnosis and Therapy in Research & Academic Laboratories
Figure 13. Global Molecular Diagnosis and Therapy Market: Research & Academic Laboratories (2020-2025) & ($ millions)
Figure 14. Global Molecular Diagnosis and Therapy Market Size Market Share by Application in 2024
Figure 15. Global Molecular Diagnosis and Therapy Revenue Market Share by Player in 2024
Figure 16. Global Molecular Diagnosis and Therapy Market Size Market Share by Region (2020-2025)
Figure 17. Americas Molecular Diagnosis and Therapy Market Size 2020-2025 ($ millions)
Figure 18. APAC Molecular Diagnosis and Therapy Market Size 2020-2025 ($ millions)
Figure 19. Europe Molecular Diagnosis and Therapy Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Molecular Diagnosis and Therapy Market Size 2020-2025 ($ millions)
Figure 21. Americas Molecular Diagnosis and Therapy Value Market Share by Country in 2024
Figure 22. United States Molecular Diagnosis and Therapy Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Molecular Diagnosis and Therapy Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Molecular Diagnosis and Therapy Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Molecular Diagnosis and Therapy Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Molecular Diagnosis and Therapy Market Size Market Share by Region in 2024
Figure 27. APAC Molecular Diagnosis and Therapy Market Size Market Share by Type (2020-2025)
Figure 28. APAC Molecular Diagnosis and Therapy Market Size Market Share by Application (2020-2025)
Figure 29. China Molecular Diagnosis and Therapy Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Molecular Diagnosis and Therapy Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Molecular Diagnosis and Therapy Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Molecular Diagnosis and Therapy Market Size Growth 2020-2025 ($ millions)
Figure 33. India Molecular Diagnosis and Therapy Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Molecular Diagnosis and Therapy Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Molecular Diagnosis and Therapy Market Size Market Share by Country in 2024
Figure 36. Europe Molecular Diagnosis and Therapy Market Size Market Share by Type (2020-2025)
Figure 37. Europe Molecular Diagnosis and Therapy Market Size Market Share by Application (2020-2025)
Figure 38. Germany Molecular Diagnosis and Therapy Market Size Growth 2020-2025 ($ millions)
Figure 39. France Molecular Diagnosis and Therapy Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Molecular Diagnosis and Therapy Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Molecular Diagnosis and Therapy Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Molecular Diagnosis and Therapy Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Molecular Diagnosis and Therapy Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Molecular Diagnosis and Therapy Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Molecular Diagnosis and Therapy Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Molecular Diagnosis and Therapy Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Molecular Diagnosis and Therapy Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Molecular Diagnosis and Therapy Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Molecular Diagnosis and Therapy Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Molecular Diagnosis and Therapy Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)
Figure 52. APAC Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)
Figure 53. Europe Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)
Figure 55. United States Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)
Figure 56. Canada Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)
Figure 57. Mexico Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)
Figure 58. Brazil Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)
Figure 59. China Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)
Figure 60. Japan Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)
Figure 61. Korea Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)
Figure 63. India Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)
Figure 64. Australia Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)
Figure 65. Germany Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)
Figure 66. France Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)
Figure 67. UK Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)
Figure 68. Italy Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)
Figure 69. Russia Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)
Figure 70. Egypt Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)
Figure 71. South Africa Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)
Figure 72. Israel Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)
Figure 73. Turkey Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)
Figure 74. Global Molecular Diagnosis and Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Molecular Diagnosis and Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Molecular Diagnosis and Therapy Market Size 2026-2031 ($ millions)